Learn more

EMENDOBIO INC

Overview
  • Total Patents
    22
  • GoodIP Patent Rank
    75,498
  • Filing trend
    ⇩ 50.0%
About

EMENDOBIO INC has a total of 22 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are BLUE SKY VACCINES GMBH, SENTI BIOSCIENCES INC and ELIGO BIOSCIENCE.

Patent filings in countries

World map showing EMENDOBIO INCs patent filings in countries

Patent filings per year

Chart showing EMENDOBIO INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Baram David 21
#2 Izhar Lior 21
#3 Emmanuel Rafi 17
#4 Herman Asael 15
#5 Georgeson Joseph 14
#6 Golan Mashiach Michal 8
#7 Rockah Liat 4
#8 Marbach-Bar Nadav 3
#9 Meron Nurit 3
#10 Diamant Noam 3

Latest patents

Publication Filing date Title
WO2021007502A2 Differential knockout of a heterozygous allele of rpe65
WO2020252361A1 Novel genome editing tool
WO2020223553A2 Novel omni crispr nucleases
WO2020223514A2 Novel omni-50 crispr nuclease
WO2020214619A1 Crispr compositions and methods for promoting gene editing of gata2
WO2020176463A1 Differential knockout of a heterozygous allele of stat1
WO2020163307A1 New engineered high fidelity cas9
WO2020163379A1 Crispr compositions and methods for promoting gene editing of ribosomal protein s19 (rps19) gene
WO2020146276A2 Crispr compostions and methods for promoting gene editing of adenosine deaminase 2 (ada2)
WO2020069029A1 Novel crispr nucleases
EP3790980A1 Differential knockout of an allele of a heterozygous elane gene
WO2019190930A2 Differential knockout of an allele of a heterozygous apolipoprotein a1 (apoa1) gene
WO2019108670A1 Differential knockout of an allele of a heterozygous fibrinogen alpha chain (fga) gene
WO2018081728A1 Compositions for genome editing
US2019330620A1 Rna compositions for genome editing
WO2017142923A1 Compositions and methods for promoting homology directed repair mediated gene editing
WO2017024047A1 Compositions and methods for increasing nuclease induced recombination rate in cells